International Stem Cell Corp. (ISCO)

[236T568]

actually, no

1. It is not a press release

2. It is an article from a newspaper, the Washington Post.

3. In involves the field of Stem Cells, which is exactly the field that ISCO is involved in.

The posted PR is unrelated to ISCO.
The stem cells used are unrelated to the type ISCO uses.
The procedure is unrelated to the procedure used in ISCO clinical trial.

All the way around, the company in the posted pr and ISCO are unrelated. But, most importantly, unrelated in type of stem cells used.